The global pelvic floor diagnostics market is projected to achieve a valuation of USD 2,056.74 million in 2023, with substantial growth anticipated over the next decade. By 2033, the market is estimated to expand to USD 3,753.39 million, reflecting a compound annual growth rate (CAGR) of 6.2%.
The report highlights a notable surge in demand for advanced diagnostic technologies, particularly uroflowmetry devices and anal manometry systems. These segments are forecasted to experience a robust CAGR of 8.2% throughout the assessment period, underscoring their increasing importance in the diagnosis and management of pelvic floor disorders.
This growth is driven by the rising prevalence of pelvic floor conditions and a growing emphasis on accurate, non-invasive diagnostic solutions. The advancement of diagnostic technologies and an increased focus on patient-centric care are fueling market expansion and innovation.
Enhancements in reimbursement structures have incentivized manufacturers to invest in the pelvic floor diagnostic sector, thereby creating a favorable environment for sustained growth through the year 2033.
Rising healthcare expenditure, along with growing government support by funding and faster approvals has led to the establishment of pelvic floor diagnostic laboratories and a larger number of professionals.
The rising number of grants by private and government players for pelvic floor diagnostics has increased the focus on innovative research solutions for the development of advanced testing systems.
Healthcare standards with advanced diagnostic procedures have gained ground during the last two decades and with the rise in income and the increased investments in research. The pelvic floor diagnostics market has experienced a substantial shift in the adoption of molecular diagnostic devices.
Key Takeaways from Pelvic Floor Diagnostics Market Study
- Ultrasound systems are expected to reach a revenue share of 37.1% in 2021 with a growing CAGR of 5.7% during the forecast period.
- Hospitals will drive sales accounting for over 60% of value share through 2031, owing to higher spending capacity.
- Mexico will reflect a 6.1% CAGR through 2031, supported by growing access to superior medical facilities.
- K. and France are leading markets in Europe, accounting for over 20% and over 18% of the Europe market respectively in 2021.
- The U.S. is North America’s largest and fastest-growing market, exhibiting a 5.7% CAGR through the forecast period.
“The growing global geriatric population is prone to pelvic floor disorders. Consequently, advancements in diagnostics including imaging and ultrasound systems, coupled with investments in research and academic bodies are set to boost the growth of the pelvic floor diagnostics market over the coming decade,” says a Future Market Insights analyst.
Investments in Tech Development to Offer Growth Opportunities
The pelvic floor diagnostics market has emerged as a lucrative area of research concerning pelvic dysfunction. The development of imaging technology is gaining traction with the rising demand for high-resolution images.
The demand is fueled by increasing awareness among the growing population about the diagnostic options available. Ultrasound systems offer reliable high-resolution imaging. The evolution in the processes involving detection, diagnosis, and treatment of associated diseases is anticipated to cause a demand surge in the pelvic floor diagnostics market.
Who is winning?
Key players in the pelvic floor diagnostics market are focusing on tapping market potential through strategic mergers and acquisitions. This is driven by efficiency in innovative and specialized product portfolios. The market is also set to expand due to increasing activities in research and development to diagnose pelvic floor disorders.
Some of the leading players in the pelvic floor diagnostics market include but are not limited to Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic, Zhuhai Seesheen Medical Technology, KARL STORZ, Cadwell, The Prometheus Group, Neurosoft, Noraxon USA.
A Old Full Report Analysis Click Here
Segments:
By Product:
- Urodynamics Systems
- Uroflowmetry Devices
- Anal Manometry Systems
- Cystoscopes
- Ultrasound Systems
- Cart/Trolley Based
- Portable Bladder Ultrasound Systems
- EMG
By End User:
- Hospitals
- Diagnostic Imaging Centers
- Specialty Clinics
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
